📰 Abt News
Page 201 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 10, 2022
Hengehold Capital Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 1,644 shares of the healthcare product maker’s stock, valued at approximately $231,000. A number of other large investors have also recently bought and sold […]
April 6, 2022
Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 648,581 shares of the healthcare product maker’s stock after selling 5,053 shares during the period. Robeco Institutional Asset […]
April 5, 2022
What i found, we need to talk abt. we cant normalize not talk about it. we need to talk about these fears and concerns like will can engage in this process, trying to make the country and themselves better. >> congrats about the book. the five influential defense. i will give you a quick sense to why? >> occupy wall street, the parkland shooting gorge floyd murder and climb change. - climate change. >> thats right. that was a gift from other generations to younger americans and that completely s...
April 5, 2022
Lurid list of bank fraud, insurance fraud schemes at the family trump real estate business. i think it t must have been unsettling for those members of the trump family that the allegations were laid out in particular to each one of them. thert filings from the new york attorney general this week, for example, stated this about ivanka trump, quote, until january 2017, ms. trump was a primary contact. thats not good when the attorney generalat says that abt you specifically and personally while a...
April 5, 2022
Victimized group and people dont know how to make sense of that. >> and just to clarify, obviously year speaking hyperbolically and not everyone with a maga hat. >> of course not. >> of course, i just want to clarify because the internet is in sane. jane, what do you think of what barry just said? >> i think one of the challenges we have is that we keep wanting to use anti-semitism or racism as a cudgel against our political opposites for getting it exists across the political spectrum. there wi...
April 1, 2022
Shares of Abbott Laboratories (NYSE:ABT – Get Rating) have been assigned an average rating of “Buy” from the eighteen research firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has issued a strong buy recommendation on […]
March 30, 2022
Shufro Rose & Co. LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,223 shares of the healthcare product maker’s stock after selling 100 shares during the quarter. […]
March 30, 2022
Regentatlantic Capital LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 90,222 shares of the healthcare product maker’s stock after acquiring an additional 1,582 shares during the period. Regentatlantic Capital LLC’s holdings in Abbott Laboratories were worth $12,698,000 as […]
March 30, 2022
Howard Financial Services LTD. acquired a new position in Abbott Laboratories (NYSE:ABT – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,535 shares of the healthcare product maker’s stock, valued at approximately $216,000. Other institutional investors and hedge funds also recently […]
March 29, 2022
NN Investment Partners Holdings N.V. reduced its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 47.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 407,598 shares of the healthcare product maker’s stock after selling 363,356 shares during the period. […]